Cingulate (CINGW) Competitors $0.04 0.00 (-0.26%) (As of 11:02 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends CINGW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROWShould you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry. Cingulate vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics Cingulate (NASDAQ:CINGW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, community ranking, analyst recommendations and profitability. Which has higher earnings and valuation, CINGW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCingulateN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media favor CINGW or ATNFW? In the previous week, Cingulate's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment Cingulate Neutral 180 Life Sciences Neutral Is CINGW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets CingulateN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community favor CINGW or ATNFW? Cingulate and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCingulateN/AN/A180 Life SciencesN/AN/A SummaryCingulate and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks. Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Get Cingulate News Delivered to You Automatically Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CINGW vs. The Competition Export to ExcelMetricCingulateBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$202.11M$5.13B$9.28BDividend YieldN/A3.54%4.81%4.06%P/E RatioN/A316.48135.2417.51Price / SalesN/A15,204.511,174.53134.92Price / CashN/A11.6740.4837.95Price / BookN/A7.264.884.94Net IncomeN/A-$18.52M$118.56M$225.30M7 Day PerformanceN/A181.94%14.97%-1.11%1 Month PerformanceN/A131.30%15.07%7.29%1 Year PerformanceN/A112.50%34.31%23.06% Cingulate Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CINGWCingulateN/A$0.04-0.3%N/A+56.0%$0.00N/A0.0013ATNFW180 Life SciencesN/A$0.01flatN/A+41.0%$0.00N/A0.007Positive NewsGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.02-51.0%N/AN/A$0.00$502,409.000.002Positive NewsGap DownHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.20-20.4%N/A+4.1%$0.00N/A0.0080News CoveragePositive NewsGap DownWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01flatN/A-72.3%$0.00N/A0.0059Gap UpBCTXWBriaCell TherapeuticsN/A$0.35-14.8%N/A-80.9%$0.00N/A0.008Gap DownCDIOWCardio DiagnosticsN/A$0.12+9.5%N/A-48.0%$0.00$35,688.000.007Positive NewsGap UpHigh Trading VolumeCTCXWCarmellN/A$0.05flatN/AN/A$0.00$32,839.000.009Positive NewsGap DownCELUWCelularityN/A$0.02flatN/A+196.3%$0.00$48.20M0.00220Positive NewsGap UpHigh Trading VolumeCEROWCERo TherapeuticsN/A$0.02flatN/AN/A$0.00N/A0.008Gap Down Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors WENAW Competitors APLMW Competitors BCTXW Competitors CDIOW Competitors CTCXW Competitors CELUW Competitors CEROW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CINGW) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.